Diabetic Perspectives

Ex-vivo Expansion of Adult Human Pancreatic Beta-Cells

Shimon Efrat

Manuscript submitted July 9, 2008; resubmitted July 15, 2008; accepted July 17, 2008.

Keywords: diabetes, beta-cell replication, dedifferentiation, ex-vivo differentiation, Notch

Abstract

Ex-vivo generation of human insulin-producing cells is considered a promising approach to providing an abundant source of cells for beta-cell replacement therapy in diabetes. Expansion of adult beta-cells from the limited number of islet donors is an attractive prospect. However, while evidence supports the replicative capacity of both rodent and human beta-cells in vivo, attempts at expanding these cells in tissue culture result in loss of beta-cell phenotype, making it difficult to track their fate during continuous propagation and raising doubts about their therapeutic potential. Recent lineage-tracing studies demonstrate the ability of human beta-cells to survive and replicate to a significant degree in vitro. Beta-cell delamination out of the normal epithelial structure, a process that results in dedifferentiation, seems to be required for significant in-vitro proliferation. Therefore, ways must be found of inducing redifferentiation of the expanded cells ex vivo, or of restoring their function upon transplantation. Elucidation of the signaling pathways altered during beta-cell adaptation to growth in culture may provide clues to cell redifferentiation. In a recent study, we found that human beta-cell dedifferentiation and entrance into the cell cycle in vitro correlated with activation of the Notch pathway and downregulation of the cell cycle inhibitor p57. Inhibition of the Notch downstream target HES1 using short hairpin RNA reduced beta-cell dedifferentiation and replication, suggesting a potential target for inducing cell redifferentiation following expansion in culture. This review critically discusses the potential for using ex-vivo beta-cell replication and redifferentiation in cell replacement therapy in diabetes.

Fulltext: HTML , PDF (695KB)

This article has been cited by other articles:

	Protective effect of N-acetylcysteine supplementation on mitochondrial oxidative stress and mitochondrial enzymes in cerebral cortex of streptozotocin-treated diabetic rats Kamboj SS, Sandhir R Mitochondrion 2011. 11(1):214-222
	Parathyroid hormone-related protein enhances human beta-cell proliferation and function with associated induction of cyclin-dependent kinase 2 and cyclin E expression Guthalu Kondegowda N, Joshi-Gokhale S, Harb G, Williams K, Zhang XY, Takane KK, Zhang P, Scott DK, Stewart AF, Garcia-Ocana A, Vasavada RC Diabetes 2010. 59(12):3131-3138
	Pancreatic cell immobilization in alginate beads produced by emulsion and internal gelation Hoesli CA, Raghuram K, Kiang RL, Mocinecova D, Hu X, Johnson JD, Lacik I, Kieffer TJ, Piret JM Biotechnol Bioeng 2010. Oct 11, epub ahead of print
	The quest for tissue stem cells in the pancreas and other organs, and their application in beta-cell replacement Houbracken I, Bouwens L Rev Diabet Stud 2010. 7(2):112-123
	Pancreatic stem/progenitor cells for the treatment of diabetes Noguchi H Rev Diabet Stud 2010. 7(2):105-111
	Beta-cells at the crossroads: choosing between insulin granule production and proliferation Liu Y, Mziaut H, Ivanova A, Solimena M Diabetes Obes Metab 2009. 11(Suppl 4):54-64
	Stem cell therapy to treat diabetes mellitus Liew CG, Andrews PW Rev Diabet Stud 2008. 5(4):203-219
	The current status of islet transplantation and its perspectives Kobayashi N Rev Diabet Stud 2008. 5(3):136-143